This inventor holds 2 USPTO granted patents. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1996-1998.
Company Filing History:
Years Active: 1996-1998
Title: Innovations by Kimio Katsuta in the Field of Medicine
Introduction
Kimio Katsuta is a prolific inventor based in Saitama, Japan, recognized for his significant contributions to medical science. With a total of two patents to his name, he has demonstrated a strong focus on developing innovative solutions that enhance healthcare outcomes.
Latest Patents
Katsuta's most recent inventions revolve around tissue plasminogen activators (t-PA). His patent titled "Tissue plasminogen activator and process of preparation" focuses on improved versions of these plasminogen activators, which exhibit a prolonged biological half-life and enhanced stability to heat and acids. These innovations are anticipated to effectively inhibit inflammation at the thrombus formation sites. Another related patent, "Tissue plasminogen activator and method of use," shares similar attributes, reaffirming Katsuta's commitment to advancing treatments in thrombotic conditions.
Career Highlights
Currently, Kimio Katsuta is employed by Yamanouchi Pharmaceutical Company Ltd., where he continues to engage in cutting-edge research and development. His work exemplifies the intersection of innovation and practical application in the pharmaceutical landscape, driving the company’s mission to improve patient care through advanced therapeutic solutions.
Collaborations
Throughout his career, Katsuta has collaborated with notable professionals such as Yasushi Kawauchi and Toshiyuki Takemoto. These partnerships have undoubtedly enhanced the innovative endeavors within their projects, fostering a collaborative environment that prioritizes scientific advancement.
Conclusion
In summary, Kimio Katsuta stands out as a key figure in the field of medical innovation, contributing with his patent-protected inventions that promise to change the landscape of thrombotic treatment. His ongoing work at Yamanouchi Pharmaceutical Company Ltd. and his collaborations with esteemed colleagues further exemplify the dynamic nature of his contributions to healthcare and innovation.